Using the MTT assay, which we and others have shown to be predictive of clinical response to fludarabine and chlorambucil,14 the median IC50 of gefitinib was 4.5 μM in ZAP-70+ CLL cells but >15 μM in ZAP-70− cells. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.